Literature DB >> 2416765

Human keratinocytes that have not terminally differentiated synthesize laminin and fibronectin but deposit only fibronectin in the pericellular matrix.

R A Clark, L D Nielsen, S E Howell, J M Folkvord.   

Abstract

Fibronectin and laminin production by human keratinocytes cultured in serum-free, low-calcium medium without a fibroblast feeder layer were examined by several techniques. By indirect immunofluorescence, fibronectin but not laminin appeared as short radial fibrils between the cells and the substratum, and in the pericellular matrix. Synthesis of fibronectin and laminin by 7-day keratinocyte cultures was determined by 18 hr 35S-methionine metabolic labeling followed by sodium dodecyl sulfate polyacrylamide gel electrophoresis and autoradiography. Fibronectin accounted for 2.9% of total synthesized protein, 26.5% of fluid phase protein secretion, and 4.3% of deposited ECM protein. In contrast, only 0.1% of the total synthesized protein was laminin, little (6.3%) of this product was secreted, and none of this product was deposited in the ECM. Our results indicate that human keratinocytes under culture conditions that prevent terminal differentiation in vitro can synthesize, secrete, and deposit fibronectin in the extracellular matrix. Although these cells synthesize laminin, they secrete very little and deposit no detectable laminin in the matrix under these culture conditions. From these data we believe that fibronectin may play an important role in the interaction of epidermal cells with connective tissue matrix during wound healing or morphogenesis in in vivo situations in which the epidermis is not terminally differentiated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2416765     DOI: 10.1002/jcb.240280206

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

Review 1.  The role of fibronectin in corneal wound healing explored by a physician-scientist.

Authors:  Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2012-07-27       Impact factor: 2.447

2.  The effect of neutrophil migration and prolonged neutrophil contact on epithelial permeability.

Authors:  P E Parsons; K Sugahara; G R Cott; R J Mason; P M Henson
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

3.  Acylceramides and lanosterol-lipid markers of terminal differentiation in cultured human keratinocytes: modulating effect of retinoic acid.

Authors:  J Brod; E Bavelier; P Justine; A Weerheim; M Ponec
Journal:  In Vitro Cell Dev Biol       Date:  1991-02

4.  Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction.

Authors:  M P Welch; G F Odland; R A Clark
Journal:  J Cell Biol       Date:  1990-01       Impact factor: 10.539

5.  Embryonic fibronectin isoforms are synthesized in crescents in experimental autoimmune glomerulonephritis.

Authors:  V Nickeleit; L Zagachin; K Nishikawa; J H Peters; R O Hynes; R B Colvin
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

6.  Thrombospondin-induced adhesion of human keratinocytes.

Authors:  J Varani; B J Nickoloff; B L Riser; R S Mitra; K O'Rourke; V M Dixit
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

7.  All-trans retinoic acid and extracellular Ca2+ differentially influence extracellular matrix production by human skin in organ culture.

Authors:  J Varani; B K Larson; P Perone; D R Inman; S E Fligiel; J J Voorhees
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

8.  Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.

Authors:  C Ffrench-Constant; L Van de Water; H F Dvorak; R O Hynes
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

9.  The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model.

Authors:  E Kawahara; Y Okada; I Nakanishi; K Iwata; S Kojima; S Kumagai; E Yamamoto
Journal:  Jpn J Cancer Res       Date:  1993-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.